|
Volumn 24, Issue 6, 2004, Pages 680-682
|
Bulimia nervosa, 5-HTTLPR polymorphism and treatment response to four SSRIs: A single-blind study [7]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CITALOPRAM;
FLUOXETINE;
FLUVOXAMINE;
PAROXETINE;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
ADOLESCENT;
ADULT;
BULIMIA;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SAFETY;
GENE EXPRESSION;
GENETIC POLYMORPHISM;
GENOTYPE;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
SIDE EFFECT;
SINGLE BLIND PROCEDURE;
ADOLESCENT;
ADULT;
BULIMIA;
HUMANS;
MEMBRANE GLYCOPROTEINS;
MEMBRANE TRANSPORT PROTEINS;
MIDDLE AGED;
NERVE TISSUE PROTEINS;
POLYMORPHISM, GENETIC;
SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;
SEROTONIN UPTAKE INHIBITORS;
SINGLE-BLIND METHOD;
|
EID: 8744266331
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/01.jcp.0000144896.83352.35 Document Type: Letter |
Times cited : (11)
|
References (5)
|